High-Grade Glioma Industry Market Expected To Grow At High Cagr During Forecast Period H2 2017

Overview

Highly grade gliomas (HGG) are tumors of the central nervous system (CNS) that arising from transformed cells of the brain and spinal cord. Symptoms include developmental delay, headaches, backaches, nausea and vomiting, dizziness, gait disturbances, impaired vision, lack of concentration, drowsiness, sleep disturbances, Dysregulated ap-petite, paralyses and seizures. Treatment includes Chemotherapy and radiation therapy.

 Click here for sample report @ http://www.wiseguyreports.com/sample-request/2740075-high-grade-glioma-pipeline-review-h2-2017

Report Highlights

The Pharmaceutical and Healthcare latest pipeline guide High-Grade Glioma - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for High-Grade Glioma (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The High-Grade Glioma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for High-Grade Glioma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are 2, 15, 13 and 5 respectively. Similarly, the Universities portfolio in Phase II and Preclinical stages comprises 1 and 3 molecules, respectively.

 Major Scope of the report:

- The pipeline guide provides a snapshot of the global therapeutic landscape of High-Grade Glioma (Oncology). 
- The pipeline guide reviews pipeline therapeutics for High-Grade Glioma (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources. 
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. 
- The pipeline guide reviews key companies involved in High-Grade Glioma (Oncology) therapeutics and enlists all their major and minor projects. 

Table of Contents 

Table of Contents 2 
List of Tables 5 
List of Figures 6 
Introduction 7 
Global Markets Direct Report Coverage 7 
High-Grade Glioma - Overview 8 
High-Grade Glioma - Therapeutics Development 9 
Pipeline Overview 9 
Pipeline by Companies 10 
Pipeline by Universities/Institutes 13 
Products under Development by Companies 14 
Products under Development by Universities/Institutes 16 
High-Grade Glioma - Therapeutics Assessment 17 
Assessment by Target 17 
Assessment by Mechanism of Action 20 
Assessment by Route of Administration 23 
Assessment by Molecule Type 25 
High-Grade Glioma - Companies Involved in Therapeutics Development 27 
AbbVie Inc 27 
Advenchen Laboratories LLC 27 

 .Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/2740075-high-grade-glioma-pipeline-review-h2-2017

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.